GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ResMed Inc (NYSE:RMD) » Definitions » Shiller PE Ratio

ResMed (ResMed) Shiller PE Ratio

: 43.53 (As of Today)
View and export this data going back to 1995. Start your Free Trial

As of today (2024-04-18), ResMed's current share price is $178.03. ResMed's E10 for the quarter that ended in Dec. 2023 was $4.09. ResMed's Shiller PE Ratio for today is 43.53.

The historical rank and industry rank for ResMed's Shiller PE Ratio or its related term are showing as below:

RMD' s Shiller PE Ratio Range Over the Past 10 Years
Min: 33.33   Med: 48.01   Max: 102.35
Current: 43.53

During the past years, ResMed's highest Shiller PE Ratio was 102.35. The lowest was 33.33. And the median was 48.01.

RMD's Shiller PE Ratio is ranked worse than
69.45% of 275 companies
in the Medical Devices & Instruments industry
Industry Median: 27.53 vs RMD: 43.53

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

ResMed's adjusted earnings per share data for the three months ended in Dec. 2023 was $1.420. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $4.09 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


ResMed Shiller PE Ratio Historical Data

The historical data trend for ResMed's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ResMed Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Shiller PE Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.20 74.10 85.38 60.24 55.64

ResMed Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.02 57.70 55.64 36.63 42.10

Competitive Comparison

For the Medical Instruments & Supplies subindustry, ResMed's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ResMed Shiller PE Ratio Distribution

For the Medical Devices & Instruments industry and Healthcare sector, ResMed's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where ResMed's Shiller PE Ratio falls into.



ResMed Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

ResMed's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=178.03/4.09
=43.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ResMed's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, ResMed's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=1.42/129.4194*129.4194
=1.420

Current CPI (Dec. 2023) = 129.4194.

ResMed Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.630 99.695 0.818
201406 0.610 100.560 0.785
201409 0.580 100.428 0.747
201412 0.640 99.070 0.836
201503 0.640 99.621 0.831
201506 0.610 100.684 0.784
201509 0.580 100.392 0.748
201512 0.680 99.792 0.882
201603 0.640 100.470 0.824
201606 0.590 101.688 0.751
201609 0.540 101.861 0.686
201612 0.540 101.863 0.686
201703 0.620 102.862 0.780
201706 0.710 103.349 0.889
201709 0.600 104.136 0.746
201712 0.070 104.011 0.087
201803 0.760 105.290 0.934
201806 0.760 106.317 0.925
201809 0.730 106.507 0.887
201812 0.860 105.998 1.050
201903 0.730 107.251 0.881
201906 0.480 108.070 0.575
201909 0.830 108.329 0.992
201912 1.100 108.420 1.313
202003 1.120 108.902 1.331
202006 1.220 108.767 1.452
202009 1.220 109.815 1.438
202012 1.230 109.897 1.449
202103 -0.540 111.754 -0.625
202106 1.330 114.631 1.502
202109 1.390 115.734 1.554
202112 1.370 117.630 1.507
202203 1.220 121.301 1.302
202206 1.330 125.017 1.377
202209 1.430 125.227 1.478
202212 1.530 125.222 1.581
202303 1.580 127.348 1.606
202306 1.560 128.729 1.568
202309 1.490 129.860 1.485
202312 1.420 129.419 1.420

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


ResMed  (NYSE:RMD) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


ResMed Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of ResMed's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


ResMed (ResMed) Business Description

Address
9001 Spectrum Center Boulevard, San Diego, CA, USA, 92123
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Executives
Brett Sandercock officer: Chief Financial Officer 17 GUINEVIERE COURT, CASTLE HILL, NEW SOUTH WALES C3 2154
Michael J. Farrell officer: Chief Executive Officer C/O REMED INC, 9001 SPECTRUM CTR. BLVD., SAN DIEGO, CA 92123
Michael J Rider officer: Global General Counsel 9001 SPECTRUM CENTER BLVD, SAN DIEGO CA 92123
Robert Andrew Douglas officer: President and COO 21 ATTUNGA ROAD, NEWPORT, NEW SOUTH WALES C3 2106
Kaushik Ghoshal officer: President, SaaS Business 9001 SPECTRUM CENTER BLVD, SAN DIEGO CA 92123
David Pendarvis officer: Chief Administration Officer REDMED INC, 14040 DANLELSON ST, POWAY CA 92064
Karen Drexler director C/O DIADEXUS, INC., 343 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO CA 94080
Justin Leong officer: President, Asia and LATAM C/O RESMED INC, 9001 SPECTRUM CENTER BLVD, SAN DIEGO CA 92123
Desney Tan director 9001 SPECTRUM CENTER BLVD, SAN DIEGO CA 92123
John Hernandez director 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA 92123
Lucile Blaise officer: President, Sleep & RC Business RESMED INC., 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA 92123
Peter C Farrell director RESMED INC, 14040 DANIELSON STREET, POWAY CA 92064-6857
James Hollingshead officer: President, Sleep Business C/O RESMED INC., 9001 SPECTRUM CENTER BOULEVARD, SAN DIEGO CA 92123
Carol Burt director C/O WELLCARE HEALTH PLANS, INC., 8725 HENDERSON ROAD, TAMPA FL 33634
Resmed Inc director 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA 92123

ResMed (ResMed) Headlines

From GuruFocus

Q4 2022 Resmed Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2023 Resmed Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q3 2022 Resmed Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Resmed Inc to Acquire Medifox Dan GmbH Call Transcript

By GuruFocus Research 01-23-2024

Resmed Inc at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 01-23-2024

Resmed Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 01-23-2024